BankPlus Trust Department Has $888,000 Stock Holdings in Encompass Health Corporation $EHC

BankPlus Trust Department boosted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 728.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,994 shares of the company’s stock after buying an additional 6,150 shares during the period. BankPlus Trust Department’s holdings in Encompass Health were worth $888,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Blue Trust Inc. raised its holdings in shares of Encompass Health by 17.4% during the third quarter. Blue Trust Inc. now owns 3,096 shares of the company’s stock worth $393,000 after acquiring an additional 458 shares during the period. CWM LLC increased its holdings in Encompass Health by 41.2% during the 3rd quarter. CWM LLC now owns 18,139 shares of the company’s stock worth $2,304,000 after purchasing an additional 5,291 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Encompass Health by 292.5% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,201 shares of the company’s stock valued at $153,000 after purchasing an additional 895 shares during the period. Legacy Wealth Asset Management LLC lifted its holdings in shares of Encompass Health by 2.6% in the third quarter. Legacy Wealth Asset Management LLC now owns 7,717 shares of the company’s stock valued at $980,000 after purchasing an additional 193 shares in the last quarter. Finally, ABLE Financial Group LLC boosted its position in shares of Encompass Health by 8.6% during the third quarter. ABLE Financial Group LLC now owns 13,971 shares of the company’s stock worth $1,775,000 after buying an additional 1,103 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on EHC shares. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. UBS Group lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Finally, Bank of America boosted their price target on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $142.86.

Encompass Health Price Performance

NYSE:EHC opened at $107.61 on Friday. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $127.99. The firm has a market capitalization of $10.83 billion, a price-to-earnings ratio of 20.34, a P/E/G ratio of 1.90 and a beta of 0.73. The stock’s 50 day moving average price is $114.32 and its two-hundred day moving average price is $117.94. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The company had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a $0.19 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is presently 14.37%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.